Building a multi-perspective scientometric approach on tentative governance in emerging technologies by Rotolo, Daniele et al.
 
 
 
 
 
Proceedings of the 2013 EU-SPRI Forum Conference 
Madrid 10-12 April 2013 
ISBN 978-84-695-7408-9          ORAL PRESENTATION 
 
Title 
Building a Multi-Perspective Scientometric Approach on Tentative 
Governance in Emerging Technologies 
 
Authors 
Daniele Rotolo, SPRU - Science and Technology Policy Research, University of Sussex 
Falmer, Brighton - BN1 9QE - United Kingdom. 
E-mail: d.rotolo@sussex.ac.uk  
 
Ismael Rafols,  Ingenio (CSIC-UPV), INGENIO, CSIC-UPV, Universitat Politècnica de València, 
Edif. 8E, Camino de Vera s/n 46022 Valencia, Spain. 
SPRU - Science and Technology Policy Research, University of Sussex, Falmer, Brighton - BN1 
9QE - United Kingdom. 
E-mail: i.rafols@sussex.ac.uk 
 
Michael Hopkins, SPRU - Science and Technology Policy Research, University of Sussex 
Falmer, Brighton - BN1 9QE - United Kingdom. 
E-mail: m.m.hopkins@sussex.ac.uk  
 
Loet Leydesdorff, Amsterdam School of Communication Research (ASCoR), University of 
Amsterdam, Kloveniersburgwal 48, Amsterdam - 1012 CX - The Netherlands 
E-mail: loet@leydesdorff.net 
 
Keywords 
Emerging science and technology; scientometrics; multi-perspective approach; cognitive 
dimension;  social dimension; geographical dimension. 
 
Note 
The paper is part of ‘Mapping the Dynamics of Emergent Technologies’ (RES-360-25-0076), a 
collaborative Open Research Area (ORA) project of SPRU (University of Sussex), IFRIS 
(University of Paris-Est, led by Philippe Larédo) and University of Amsterdam (Loet 
Leydesdorff).  
Proceedings of the 2013 EU-SPRI Forum Annual Conference 
 
 -2- 
EXTENDED ABSTRACT 
Emerging technologies have the potential to generate profound - both positive and 
negative - social changes such as creating new industries as well as 
reconfiguring/destroying existing ones. Defining governing arrangements for emerging 
technologies is however a complex activity given the uncertainties and dynamics that 
feature in their emergence process. The development of novel technologies may follow 
some directions rather than others as a result of a variety of factors. These including the 
visions, goals and expectations the constellation of involved actors have on them (e.g. 
Geels, 2002; Wiek et al., 2007; Stirling, 2009). These actors of the innovation dynamics, are 
at the same time being regulated, and actively influencing (i.e. actually regulating) the 
emergence process by attempting to steer the intentional government arrangements 
(Braithwaite and Drahos, 2000). Rip (2010) refers in this sense to concept of de facto 
governance.  
In this configuration, traditional forms of governance are unsuitable because of their 
highly routinized and structured nature, which in times of more incremental change gives 
them legitimacy. Novel governance approaches instead aiming to address the complexity, 
interdependencies, and contingencies characterizing the process of emergence have started 
to appear. The main characteristic distinguishing these novel approaches to the traditional 
ones is their ‗tentative‘ nature (e.g. Hagendijk and Irwin, 2006; Boon et al., 2011). Forms of 
governance that are tentative aim to create a space where the generation of a number of 
options for the development of emerging technologies is desired and supported. Our 
understanding of this phenomenon is however limited. Policy makers and researchers need 
tools that are capable of capturing, in a timely and informative manner, the dynamics of the 
emergence process. 
In this regard, scientometrics represents a valuable source. We propose a multi-
perspective scientometric approach that has the potential to identify connections between 
structure and dynamics, and the governance, which in turn is a scarcely investigated area of 
research. The approach builds on several data sources (e.g. publications, patents, inter-
organisational alliances) that portray different analytical lenses at various levels of 
aggregation (e.g. individual, organisation, discipline). The intersection between data sources 
and units of analysis defines perspectives (Figure 1) that can be observed across time to 
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capture evolutionary dynamics.1 By using scientometric techniques the different 
perspectives may serve as informative and interpretative tool of de facto governance across 
three distinct but interdependent dimensions of the emergence process, i.e. cognitive, 
social, and geographical ones. 
 
Figure 1. Multi-perspective approach: combining data sources and units of analysis. 
 
Firstly, scientometrics has developed robust mapping techniques to dynamically and 
timely trace the structure of the cognitive dimension. These techniques mainly use two 
types of data, i.e. publications and patents. Until recently, scholars‘ efforts in using 
publication data have been focused on the development of maps of science circumscribed 
only to the publications of the topics (e.g. co-citation, co-words maps). In the last decade, 
an important development has been the creation of so-called global maps of science, which 
represent all science in one map in terms of disciplines, journals, or research topics (e.g. 
Klavans and Boyack, 2009; Rafols et al., 2010). Overlay techniques can be applied to this 
map in order to project an entity‘s (e.g. individual, organisation) publishing activity. Among 
these maps it is worth mentioning the global map of science  (Klavans and Boyack, 2009; 
Rafols et al., 2010)—based on the ISI Web of Science subject categories—and the Medical 
Subject Headings (MeSH) map (Leydesdorff et al., 2012)—based on the 
PubMed/MEDLINE MeSH terms, which provide the practitioners‘ view on the use of 
                                                 
1 The multi-perspective approach is flexible, i.e. it does not limit to the perspectives reported in Figure 1. Yet, 
it can be extended by including additional data sources and units of analysis. 
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medical knowledge. Efforts have been also undertaken to build maps based patent 
technological classes (e.g. Leydesdorff et al., Forthcoming). Secondly, the structure of the 
relationships between actors surrounding novel technologies and its dynamics play a critical 
role in the emergence process (e.g. Latour, 1993; Klijn and Koppenjan, 2000). These 
connections are channels through which actors gain access to and mobilise knowledge, 
resources, and power. The use of co-authorship data in publications to trace network and 
social dynamics has a long tradition in scientometrics (Crane, 1972). Co-invention activities 
and inter-organisational alliances data represent also valuable sources to build additional 
perspectives. Thirdly, the geographical diffusion of emerging technologies can also be 
traced. Scientometricians have developed also in this case a number of applications to 
localise the production of publications and patents (e.g. Leydesdorff and Bornmann, 2012).  
The paper will discuss the multi-perspective scientometric approach across three 
illustrative case studies in the life science: (i) RNA interferences (RNAi), (ii) Human 
Papillomavirus (HPV) diagnostics and (iii) Thiopurine Methyltransferase (TPMT) testing.  
RNA interference. RNAi is a technique for gene silencing that has the potential to 
stop the progression of a given disease. This gene silencing mechanism was discovered in 
1998 (Fire et al., 1998) and its discovery reshaped the landscape of research on therapies 
based on control of gene expression creating important expectations on the therapeutic 
applications (e.g. Sung and Hopkins, 2006). One of the main characteristics of RNAi is that 
it can be conceived as a ―general purpose technology‖ for research in labs (Youtie et al., 
2008). In this regard, by mapping the publication activity with overlay techniques applied to 
the global map of science (Leydesdorff and Rafols, 2011) the diffusion and impact of 
RNAi across a number of diverse fields of science is revealed, thus informing on the 
cognitive dynamics of de facto governance. Figure 2a depicts the disciplinary overlay map for 
the 2007-2011 period.2 The social dimension can be also traced by using collaboration 
networks as reported in Figure 2b. This informs on the structure of the inter-organisational 
alliances networks of companies involved in the development of RNAi revealing that the 
two key players, i.e. Alnylam Pharmaceuticals and ISIS Pharmaceuticals (grey nodes), are 
strongly connected and positioned at the centre of the network. Finally, publishing and 
patenting activities can be projected on Google Maps to investigate the geographical 
dimension (e.g. Leydesdorff and Bornmann, 2012). The collaboration activity (co-
authorships) across different cities on Google Maps (Figure 2c) (Leydesdorff and Rafols, 
                                                 
2 ISI subject categories are grouped in 19 macro-areas. A different colour is assigned to each macro-area (for 
further details see Rafols et al., 2010). 
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2011) allows identifying locations of and interactions among the constellation of actors 
involved in de facto governance. 
HPV diagnostics. The second case study is related to the development of a diagnostic 
technology for the detection of HPV. In the 1980s, HPV viruses were discovered strongly 
associated with cervical cancer in women, which has a significant impact on population—
about 500,000 new cervical cancers and 250,000 deaths each year. This has led to the 
development of a large screening program with 100+ million tests performed annually. 
While this screening has been mainly performed by using the Pap-test, the discovery on the 
association between HPV and cervical cancer opened the space for the development of a 
competing and more sensitive technology for the detection of the HPV and then of the 
cervical cancer based on molecular diagnostics technology, namely the HPV testing 
(Casper and Clarke, 1998; Hogarth et al., 2012). In this process, Digene Corp. played a 
crucial role in establishing the HPV-test as gold standard. (Hogarth et al., 2012). We 
reported in Figure 2d the inter-organisational network (co-authorships from 1997 to 
2001).3 Digene and the organisations to which the company was directly connected are 
represented with yellow and red nodes, respectively. The network reveals the social 
structure of the de facto governance since a detailed analysis shows Digene collaborating 
with main institutions in the field (e.g. National Cancer Institute, Kaiser Permanente) 
involved in the regulation of the cervical cancer screening. In other words, while Digene‘s 
activity was ‗regulated‘ (e.g. FDA approval), Digene was affecting the developments and 
dynamics in cervical cancer screening. 
TPMT testing. The third case study is focused on an emerging class of 
Pharmacogenetic tests (which predict adverse events affecting patient‘s health) (Hopkins et 
al., 2006), i.e. the TPMT testing. TPMT is an enzyme in the human body responsible for 
metabolising thiopurine drugs. Cytotoxic Thiopurine drugs are used to treat a range of 
conditions including leukaemia, and autoimmune diseases. However, where a patient has 
mutations in the gene encoding TPMT, they may be at increased risk of toxicity from a 
build up of thiopurines. Therefore, several types of TPMT test started to emerge across a 
number of clinical fields of use. Some of the tests are based on patented technology (with 
an IP holder that seeks to aggressively exploit their exclusivity in certain markets such as 
the USA, but not in others such as the UK). The relatively small market for the (off-patent) 
thiopurine drugs represents a small ‗niche‘ made up of other niches such as transplantation, 
                                                 
3 We reported only the giant component and the nodes‘ size is proportional to organisations‘ degree 
centrality. 
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gastroenterology, and rheumatology. In these different niches, evidence of clinical utility of 
the test is highly contested. In this case, tentative governance occurs through medical 
guidelines which report significant differences in the use of TPMT testing. Investigating 
the cognitive structure of the emergence process can reveal for instance different 
translations and interpretations of basic knowledge on TPMT.  
 
While the present extended abstract has reported only some key examples of the 
application of the multi-perspective scientometric approach, the full paper will 
comprehensively discuss this approach across the three case studies. Particular attention 
will be paid in integrating the outputs of the approach under the lens of de facto governance 
and the extent to which these outputs can inform, in a timely manner, policy makers and 
researchers. 
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Figure 2. The multi-perspective scientometric approach, techniques, and examples. 
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